Role of protein kinase C in advanced glycation end products-induced epithelial-mesenchymal transition in renal proximal tubular epithelial cells

Abstract

The role of protein kinase C (PKC) activation in advanced glycation end products (AGEs)-induced epithelial-mesenchymal transition in renal proximal tubular epithelial cells was investigated. HKC cells were divided into three groups: normal group, AGE-BSA group (100 mg/L AGE-BSA) and AGE-BSA+PKC inhibitor (10 μmol/L chelerythrine chloride) group. PKC activity was measured by PKC assay kit. The expression of Vimentin, and phosphorylated β-catenin was detected by using Western blotting, and the content of TGF-β1 was examined by ELISA method. The intracellular disposition of Vimentin was observed by fluorescence microscopy. As compared with normal group, PKC activity was increased significantly in AGE-BSA group. The expression of Vimentin, phosphorylated β-catenin, and TGF-β1 was enhanced significantly in AGE-BSA group. The expression of Vimentin, phosphorylated β-catenin, and TGF-β1 was significantly blocked by chelerythrine chloride. High expression of Vimentin, phosphorylated β-catenin, and TGF-β1 induced by AGE-BSA may be mediated via the activation of PKC signal transduction pathway.

Keywords

protein kinase C / advanced glycation end products / epithelial-mesenchymal transition

References

[1] HuebschmannA.G., RegensteinerJ.G., VlassaraH., et al. . Diabetes and advanced glycoxidation end products. Diabetes Care, 2006, 29(6): 1420-1432

[2] BohlenderJ.M., FrankeS., SteinG., et al. . Advanced glycation end products and the kidney. Am J Physiol Renal Physiol, 2005, 289(4): F645-F659

[3] SimonsonM.S.. Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int, 2007, 71(9): 846-854

[4] NgY.Y., HuangT.P., YangW.C., et al. . Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int, 1998, 54(3): 864-876

[5] JindeK., Nikolic-PatersonD.J., HuangX.R., et al. . Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis, 2001, 38(4): 761-769

[6] OldfieldM.D., BachL.A., ForbesJ.M., et al. . Advanced glycation end products cause epithelial-myofibroblast trans-differentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest, 2001, 108(12): 1853-1863

[7] Noh H, King GL. The role of protein kinase C activation in diabetic nephropathy. Kidney Int Suppl, 2007(106): S49–S53

[8] LiJ., GobeG.. Protein kinase C activation and its role in kidney disease. Nephrology (Carlton), 2006, 11(5): 428-434

[9] LeeT.S., SaltsmanK.A., OhashiH., et al. . Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A, 1989, 86(13): 5141-5145

[10] BradfordM.M.. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 7(72): 248-254

[11] OoieT., TakahashiN., NawataT., et al. . Ischemia-induced translocation of protein kinase C-epsilon mediates cardioprotection in the streptozotocin-induced diabetic rat. Circ J, 2003, 67(11): 955-961

[12] PhillipsA.O., SteadmanR.. Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol, 2002, 17(1): 247-252

[13] Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Tubulointerstitial damage and progression of renal failure. Kidney Int Suppl, 2005(99):S82–S86

[14] LaneA., JohnsonD.W., PatB., et al. . Interacting roles of myofibroblasts, apoptosis and fibrogenic growth factors in the pathogenesis of renal tubulo-interstitial fibrosis. Growth Factors, 2002, 20(3): 109-119

[15] RastaldiM.P.. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis. J Nephrol, 2006, 19(4): 407-412

[16] LiJ.H., WangW., HuangX.R., et al. . Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol, 2004, 164(4): 1389-1397

[17] LilienJ., BalsamoJ., ArreguiC., et al. . Turn-off, drop-out: functional state switching of cadherins. Dev Dyn, 2002, 224(1): 18-29

[18] LilienJ., BalsamoJ.. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol, 2005, 17(5): 459-565

[19] XuG., ArreguiC., LilienJ., et al. . PTP1B modulates the association of beta-catenin with N-cadherin through binding to an adjacent and partially overlapping target site. J Biol Chem, 2002, 277(51): 49 989-49 997

[20] XuG., CraigA.W., GreerP., et al. . Continuous association of cadherin with beta-catenin requires the non-receptor tyrosine-kinase Fer. J Cell Sci, 2004, 117(Pt15): 3207-3219

[21] ZengR., YaoY., HanM., et al. . Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt. J Am Soc Nephrol, 2008, 19(2): 380-387

[22] Pantsulaia T. Role of TGF-beta in pathogenesis of diabetic nephropathy. Georgian Med News, 2006(131):13–18